Zimmer Biomet Stock Plunges 15% as Guidance Cut Triggers Securities Fraud Probe
Zimmer Biomet stock fell 15.2% after cutting organic revenue guidance to 4.0% from 4.5%, citing emerging market weakness and U.S. revision slowdown. Securities investigation launched.
ZBHsecurities fraudstock decline